Life Sciences in the Kingdom of Saudi Arabia (KSA) and the Gulf Corporation Council (GCC) continue to develop at a rapid pace. This growth is fueled by supportive national policies encouraging innovation, research & development, and commercialization. KSA and its neighboring countries are investing in Life Sciences R&D, healthcare and biotechnology.
UFC Biotechnology established a Joint-Venture named UFC Biotech with the Ministry of National Guard Health Affairs (MNG-HA) and its subsidiary King Abdullah International Medical Research Center (KAIMRC) to manufacture needed cell and microbial culture media & supplements in the area, and take advantage of the market potential. This company will provide a continually evolving portfolio of products designed to meet every day R&D needs for the growing area of molecular biology and life sciences within the Kingdom and the region. Collaboration with research and education institutions recognized nationally, and internationally, to drive innovation within this company is vital to its future status as a world-class biomedical precinct, and its contribution to high levels of life sciences research, education and economic benefits in Saudi Arabia.
UFC Biotech, located at the Medical Biotechnology Park, supports product development programs for life sciences inventions resulting from national research activities and will support the government’s drive to reduce the reliance on expensive imported laboratory reagents and kits. The goal is to provide lower cost, just in time and high quality products currently imported by the life sciences research, educational and health institutions.